Risk-benefit associated with Azithromycin: A brief review
Journal Title: Journal of Pharmacovigilance and Drug Research - Year 2020, Vol 1, Issue 20201201
Abstract
Azithromycin is the most popular prescribed antimicrobial agent around the world. It comes under the class of macrolide antibiotics. Because of its higher efficacy, tolerance, and broad-spectrum activity, it is primarily used in upper and lower respiratory tract infections, some sexually transmitted infections, and major bacterial infections. Generally, this is commercially available in solids, liquids, and ophthalmic formulations due to its minimal adverse events. It is also using in the case of COVID-19 drug therapy due to its pharmacological and therapeutic properties but a review of literature presented that it may increase the risk of cardiac death, hepatic injury, ototoxicity, hypersensitivity reactions.
Authors and Affiliations
Anil Kumar Pradhan1*, Ajit Nahak2, Gyanendra Narayan Mohapatra1
Keywords
Related Articles
- EP ID EP690856
- DOI 10.5281/zenodo.4298904
- Views 165
- Downloads 0
Cutaneous Adverse Drug Reactions in a Tertiary Care Hospital: An Observational Study
Cutaneous adverse drug reactions (CADRs) are one of the most common ADRs caused by drugs causing a lot of morbidity and mortality. The overall incidence of CADRs in developed countries is 1-3 %, while that in the develop...
Materiovigilance: Current status in India analogous to its global status
Medical devices are boon to the healthcare system and are available in the market since long ago. More than 500,000 different types of the medical devices are available in the international market. Thus, from the patient...
Risk-benefit associated with Azithromycin: A brief review
Azithromycin is the most popular prescribed antimicrobial agent around the world. It comes under the class of macrolide antibiotics. Because of its higher efficacy, tolerance, and broad-spectrum activity, it is primarily...
Artificial Neural Network: A Data Mining Tool in Pharmacovigilance
Pharmacovigilance ensures patients safety as well as drug safety. In India, there is still a lot to be done and learned to ensure that the work and activities done in the area of pharmacovigilance are safely implemented....
Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide
Dytor plus tablet is a fixed-dose combination of torsemide and spironolactone used for generalized edema. TEN is a serious, potentially life-threatening dermatological disorder. Here we present a case report of a 47-year...